Myriad Genetics Inc

More

• Myriad Genetics shares rise to three-year highs Tuesday, 14 May 2013 | 5:39 PM ET

  NEW YORK-- Shares of diagnostic test maker Myriad Genetics Inc. rose to a three-year high Tuesday, as analysts said actions by the Supreme Court and actress Angelina Jolie could both help the company. On Monday the U.S. Supreme Court upheld Monsanto Co.' s claim that a farmer in Indiana violated one of its patents on soybean seeds.

• Jolie's Decision Boosts BRCA Test-Maker Myriad Tuesday, 14 May 2013 | 1:53 PM ET

  

  Shares of genetic test maker rose 4 percent, after actress Anjolina Jolie said to undergo double-mastectomy, following testing which showed she carried a gene for breast cancer.

• BRIEF-Myriad Genetics up 3.3 percent in extended trade Tuesday, 7 May 2013 | 5:08 PM ET

  NEW YORK, May 7- Myriad Genetics Inc:.

• Designer Genes: Court to Decide on DNA Patents Monday, 15 Apr 2013 | 7:14 AM ET

  

  The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.

• PREVIEW-U.S. top court weighs patentability of human genes Sunday, 14 Apr 2013 | 1:45 PM ET

  *Oral arguments begin Monday in Myriad Genetics patent suit. NEW YORK, April 14- Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder.

• Herbalife short-seller sues banks, Icahn over alleged fraud Wednesday, 13 Mar 2013 | 2:02 PM ET

  *Banks accused of failing to withdraw Herbalife financing. March 13- A short seller in Herbalife Ltd's stock has sued officials at three major U.S. banks as well as activist investor Carl Icahn, saying they are helping perpetuate a fraudulent pyramid scheme at the nutritional products company.

• Australian court supports patents on human genes Thursday, 14 Feb 2013 | 11:37 PM ET

  *U.S. Supreme Court to consider same issue in April. CANBERRA, Feb 15- An Australian court ruled on Friday that two technology companies could hold a patent on genetic material related to cancer, in a case similar to one before the U.S. Supreme Court that has implications for gene-based medicine worldwide.

• Midday Movers: F, RIG & More Thursday, 3 Jan 2013 | 1:53 PM ET

  

  Take a look at some of Thursday's midday movers:

• After-Hours Buzz: LTD, GILD & More Monday, 10 Dec 2012 | 5:10 PM ET

  

  Check out which companies are making headlines after the bell Monday.

• Midday Movers: GMCR, LULU & More Monday, 3 Dec 2012 | 12:16 PM ET

  

  Take a look at some of Monday's midday movers:

• UPDATE 2-U.S. Supreme Court to decide if human genes patentable Friday, 30 Nov 2012 | 5:21 PM ET

  *Myriad Genetics sought to patent genes linked to cancer. The nation's highest court in a brief order agreed to review a case over whether Myriad Genetics Inc may patent two genes linked to hereditary breast and ovarian cancer.

• UPDATE 1-U.S. Supreme Court to decide if human genes patentable Friday, 30 Nov 2012 | 4:07 PM ET

  *Myriad Genetics sought to patent genes linked to cancer. The nation's highest court agreed to review a case over whether Myriad Genetics Inc may patent two genes linked to hereditary breast and ovarian cancer.

• U.S. Supreme Court to decide if human genes are patentable Friday, 30 Nov 2012 | 3:31 PM ET

  Nov 30- The U.S. Supreme Court on Friday agreed to decide whether human genes can be patented, a hotly contested issue with broad consequences for the future of gene-based medicine. The nation's highest court agreed to review a case over whether Myriad Genetics Inc may patent two genes linked to hereditary breast and ovarian cancer.